Concepedia

Danai Dima

DD

Statistics

Publications

31

Citations

1.3K

H-Index

18

Active since

2022

Affiliations

Cleveland Clinic(Current)

Medical University of South Carolina

University of Kansas Medical Center

The University of Texas Southwestern Medical Center

Levine Cancer Institute

Danai Dima is an author at Cleveland Clinic specializing in immunotherapy, multiple myeloma therapy, and multiple myeloma.

Publications per year

2022–2025

31

Publications

31

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Doris K. Hansen, Surbhi Sidana, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 279 citations · Full text

Medicine, Immunology, Oncology +15

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 124 citations · Full text

Medicine, Hematology, Oncology +14

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi et al. · Blood Cancer Journal · 2023 · 111 citations · Full text

Medicine, Hematology, Oncology +17

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

Nico Gagelmann, Danai Dima, Maximilian Merz et al. · Journal of Clinical Oncology · 2024 · 83 citations · Full text

Medicine, Immunology, Oncology +17

Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience

Danai Dima, James A. Davis, Nausheen Ahmed et al. · Transplantation and Cellular Therapy · 2023 · 78 citations

Medicine, Oncology, Pharmacotherapy +14

1–5 of 31